Rybelsus®

Rybelsus
Manufacturer: Novo Nordisk India Pvt Ltd

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.

3mg

Package Savings Per tablet Price Order
90 tablets QAR 1636.50 QAR 54.60 QAR 4913.68
  • Free AirMail shipping
60 tablets QAR 872.67 QAR 58.24 QAR 3494.12
  • Free AirMail shipping
30 tablets QAR 327.23 QAR 61.87 QAR 1856.17
  • Free AirMail shipping
20 tablets QAR 145.41 QAR 65.51 QAR 1310.18
  • Free AirMail shipping
10 tablets QAR 72.78 QAR 727.80
  • Free AirMail shipping

7mg

Package Savings Per tablet Price Order
90 tablets QAR 653.73 QAR 65.52 QAR 5896.46
  • Free AirMail shipping
60 tablets QAR 326.68 QAR 67.34 QAR 4040.11
  • Free AirMail shipping
30 tablets QAR 108.83 QAR 69.15 QAR 2074.56
  • Free AirMail shipping
20 tablets QAR 36.22 QAR 70.97 QAR 1419.38
  • Free AirMail shipping
10 tablets QAR 72.78 QAR 727.80
  • Free AirMail shipping

14mg

Package Savings Per tablet Price Order
90 tablets QAR 817.52 QAR 78.26 QAR 7043.02
  • Free AirMail shipping
60 tablets QAR 435.88 QAR 80.07 QAR 4804.49
  • Free AirMail shipping
30 tablets QAR 163.43 QAR 81.89 QAR 2456.75
  • Free AirMail shipping
20 tablets QAR 72.62 QAR 83.71 QAR 1674.17
  • Free AirMail shipping
10 tablets QAR 87.34 QAR 873.39
  • Free AirMail shipping

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.